Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: On 18 February 2008, the subject received the first dose of ROTARIX vaccine. On 17 April 2008, the subject received the second dose of ROTARIX vaccine. This case was reported by a physician in the frame of a study and described the occurrence of intussusception in a 5-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject had no relevant medical history. No concomitant medication given. On 17 April 2008, the subject received 2nd dose of ROTARIX (oral). On 14 May 2008, 27 days after 2nd vaccination with ROTARIX, the subject experienced intussusception, adenomegaly, nausea, hyperperistalsis, hematochezia, fever, blood present in stool and ileus. The subject was hospitalised. Relevant test results included x-ray abdominal evidenced lack of distal air and abnormal distribution of intestinal gas. Intussusception was suspected and surgery was done on 19 May 2008, small bowel loops and colon exploration was done. Finding intestinal ischemia with vascular recuperation and mesenteric adenopathy, intestinal resection was not necessary, the surgeon confirmed that intussusception has spontaneous resolution. The subject showed Ileus after abdominal surgery, however the clinical evolution evidenced improvement without complication. The subject was treated with paracetamol, ranitidine, metamizol, clindamycin and amikacin. On 23 May 2008, the events were resolved. He was discharged with diagnosis of intestinal invagination on 23 May 2008, with good oral acceptance, digestion favorable and normal colonic function. Other diagnosis at discharge was adenomegaly mesenteric. The physician considered the events were related to vaccination with ROTARIX.
Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166